Depressed Mood and Anhedonia in Healthy Adults
NCT05306093 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 94
Last updated 2022-09-07
Summary
The aim of this study is to evaluate the effect of nutraceutical supplement on depressed mood and anhedonia in volunteers after 8 weeks of consumption.
Conditions
- Anhedonia
- Depressed Mood
Interventions
- DIETARY_SUPPLEMENT
-
Nutraceutical
Food supplements are consumed during 8 weeks by healthy volunteers
- DIETARY_SUPPLEMENT
-
Maltodextrin
Food supplements are consumed during 8 weeks by healthy volunteers
Sponsors & Collaborators
-
Institut Pasteur de Lille
lead OTHER
Principal Investigators
-
Zakaria NAFLI, MD · CEN Experimental
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-07
- Primary Completion
- 2022-09-01
- Completion
- 2022-09-01
Countries
- France
Study Locations
More Related Trials
-
Effects Of Antidepressants On Sexual Functioning In Adults
NCT00051272 ·Status: COMPLETED ·Phase: PHASE3
-
Psilocybin for Treatment-Resistant Depression
NCT06230757 ·Status: COMPLETED ·Phase: PHASE2
-
Neural Responses and Dysphoria: Modulation by a Pharmacological Probe
NCT01101685 ·Status: COMPLETED ·Phase: PHASE4
-
Cannabidiol for Treatment Resistant Depression
NCT04732169 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
NCT06263660 ·Status: RECRUITING ·Phase: PHASE2
-
Psilocybin for Major Depressive Disorder (MDD)
NCT06308653 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
NCT06656702 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effects of Antidepressants on Sexual Functioning
NCT00051259 ·Status: COMPLETED ·Phase: PHASE3
-
Mood Effects of Serotonin Agonists: Depression
NCT07017478 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Adjunctive Game Intervention for Anhedonia in MDD Patients
NCT04977232 ·Status: COMPLETED ·Phase: NA
-
The Effects of Bifidobacterium Longum 1714® in a Population With Low Mood
NCT04925440 ·Status: COMPLETED ·Phase: NA
-
Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers
NCT00536679 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of HS-10353 in Adult Participants With Major Depressive Disorder
NCT05938179 ·Status: UNKNOWN ·Phase: PHASE2
-
Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive Disorder
NCT03899194 ·Status: UNKNOWN ·Phase: NA
-
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00250601 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Escitalopram on Cytokines
NCT01587326 ·Status: UNKNOWN ·Phase: NA
-
A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders
NCT04226963 ·Status: COMPLETED
-
The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD
NCT00163059 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder
NCT06692361 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
NCT00252330 ·Status: COMPLETED ·Phase: PHASE3
-
A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression
NCT00250653 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients
NCT01352572 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Study in Patients With Major Depressive Disorder
NCT00896363 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
NCT05220410 ·Status: COMPLETED ·Phase: PHASE2
-
Circadian Effects of Escitalopram
NCT01214044 ·Status: COMPLETED ·Phase: NA